CURRAN TERRIE sold 4.4% of their position (1.07K shares) of ARCUTIS BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $27.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/24/2026ACC: 0001628280-26-058648
Director
Since Nov 2020
-1.07K
Net shares
Net seller
$27.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.07K acquired · 2.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.07K
Price / share
$7.51
Trade value
$8.05K
% of position
4.6%
8/20/2026
23.53K→24.60K
Common Stock
Direct
Shares
−1.07K
Price / share
$26.04
Trade value
$27.91K
% of position
4.4%
8/20/2026
24.60K→23.53K
Total
Net shares
+0.00
Net value
-$19.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/20/2026 | M · Option Exercise | +1.07K | $7.51 | $8.05K | 4.6% | 23.53K | 24.60K |
| Common Stock Direct | 8/20/2026 | S · Sale | −1.07K | $26.04 | $27.91K | 4.4% | 24.60K | 23.53K |
| Total | +0.00 | -$19.86K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
1.07K shares
Shares
−1.07K
Strike price
7.51
Held after
11.15K
Exercisable
—
8/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock1.07K shares | 8/20/2026 | M · Option Exercise | −1.07K | 7.51 | — | 11.15K |